Current systems of care for patients with suspected LVO involve pre-hospital triage which routes patients either directly to a stroke center capable of mechanical thrombectomy, or initially to a nearer hospital without endovascular capability, but which may still offer intravenous tissue plasminogen activator (IV-tPA). This evidence concerns the gene PLAT and stroke disorder.